NUTRA PHARMA CORP
NUTRA PHARMA CORP
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Cash | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Security Deposit | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Accrued Salaries Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Contract With Customer Liability Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Derivative Liabilities Current | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Long Term Debt Current | - | - | 10 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 22 | 18 | 17 | 17 | 17 | 17 | 15 | 15 | 15 | 15 | 14 | 14 | |||||
Secured Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 22 | 18 | 17 | 17 | 17 | 17 | 15 | 15 | 15 | 15 | 14 | 14 | |||||
Equity | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Additional Paid In Capital Common Stock | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | |||||
Retained Earnings Accumulated Deficit | -83 | -79 | -78 | -78 | -77 | -78 | -76 | -76 | -76 | -75 | -75 | -75 | |||||
Stockholders Equity | -21 | -17 | -17 | -16 | -16 | -16 | -15 | -15 | -15 | -14 | -14 | -14 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | |||||
Common Stock Shares Issued | 7,160 | 7,160 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,065 | 7,065 | 7,065 | |||||
Shares Outstanding | 7,160 | 7,160 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,065 | 7,065 | 7,065 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.00% | 200.00% | 0.00% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.00% | 200.00% | 0.00% | 100.00% | 200.00% | 0.00% | 200.00% | 0.00% | 100.00% | 0.00% | 200.00% | 0.00% |
| 2024 | -90.00% | -80.00% | -90.00% | -90.00% | -80.00% | -90.00% | -33.33% | -66.67% | -66.67% | -50.00% | 0.00% | 50.00% |
| 2023 | 0.00% | 500.00% | 200.00% | 0.00% | 900.00% | 0.00% | 400.00% | 900.00% | 0.00% | 66.67% | -83.33% | -66.67% |
| 2022 | - | - | - | - | - | - | - | - | - | 0.00% | 0.00% | 400.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |||||
| Quick Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||
| Working Capital | -21.23M | -17.24M | -16.81M | -16.38M | -15.89M | -16.30M | -14.89M | -14.90M | -14.64M | -14.28M | -13.86M | -13.59M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.03 | -1.04 | -1.03 | -1.04 | -1.05 | -1.05 | -1.04 | -1.04 | -1.04 | -1.04 | -1.05 | -1.05 | |||||
| Interest Coverage TTM | -3.88 | -3.56 | -3.51 | -3.19 | -3.02 | -2.98 | -2.91 | -2.64 | -2.56 | -2.42 | -2.33 | -3.55 | |||||
| Debt Ratio | 35.05 | 29.00 | 29.78 | 24.03 | 19.43 | 21.91 | 25.70 | 27.52 | 24.07 | 23.86 | 22.50 | 20.01 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.22 | 0.30 | 0.44 | 0.49 | 0.42 | 0.40 | 0.40 | 0.33 | 0.27 | 0.28 | 0.29 | 0.34 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | - | 38.94 | 43.03 | 42.34 | 39.15 | 33.46 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | 9.37 | 8.48 | 8.62 | 9.32 | 10.91 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 78.15% | 74.20% | 76.33% | 88.12% | 88.73% | 96.00% | 100.41% | 120.34% | 158.84% | 174.05% | 192.86% | 187.86% | |||||
| Operating Profit Margin TTM | -1,017.76% | -707.39% | -567.65% | -378.37% | -318.34% | -330.18% | -356.63% | -397.12% | -436.39% | -415.10% | -431.49% | -744.42% | |||||
| Net Profit Margin TTM | -3,370.64% | -522.63% | -794.76% | -576.19% | -484.17% | -801.15% | -521.97% | -613.72% | -699.48% | -650.37% | -677.82% | 876.43% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -49.01% | -25.36% | 4.59% | 46.89% | 67.67% | 49.68% | 19.82% | -10.97% | -10.66% | 1.19% | 40.99% | 155.94% | |||||
| Net Income Growth (1Y) | 254.99% | -51.31% | 59.25% | 37.91% | 16.06% | 84.38% | -7.73% | -162.34% | -144.79% | -147.76% | -117.04% | -70.56% | |||||
| EPS Growth (1Y) | 240.74% | -53.34% | 57.09% | 35.10% | 14.77% | 83.56% | -8.52% | -161.99% | -144.44% | -147.47% | -116.81% | -70.64% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.30 | -0.73 | -0.38 | -0.44 | -0.51 | -0.68 | -0.60 | -0.59 | -0.58 | -0.62 | -0.55 | 0.37 | |||||
| P/B TTM | -0.08 | -0.05 | -0.05 | -0.05 | -0.05 | -0.09 | -0.05 | -0.05 | -0.05 | -0.05 | -0.06 | -0.06 | |||||
| P/S TTM | 10.03 | 3.80 | 3.02 | 2.52 | 2.46 | 5.43 | 3.12 | 3.62 | 4.07 | 4.05 | 3.70 | 3.21 | |||||
| Market Cap | 1.61M | 801.14K | 777.89K | 781.62K | 774.30K | 1.54M | 767.37K | 765.71K | 765.71K | 764.33K | 760.75K | 761.34K | |||||
| Enterprise Value | 1.76M | 928.47K | 914.87K | 927.19K | 844.40K | 1.67M | 880.09K | 915.61K | 915.61K | 914.23K | 910.65K | 937.73K | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -1.08M | -1.14M | -1.24M | -1.17M | -904.62K | -855.02K | -595.16K | -603.18K | -706.44K | -628.46K | -550.04K | -417.84K | |||||
| Net Debt | 149.17K | 127.33K | 136.99K | 145.57K | 70.10K | 135.33K | 112.72K | 149.90K | 149.90K | 149.90K | 149.90K | 176.39K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
NUTRA PHARMA CORP (NPHC) — SEC Financial Statements & Analysis
NUTRA PHARMA CORP (NPHC) is a medicinal chemicals & botanical products company, incorporated in CA. NUTRA PHARMA CORP trades on OTC as: NPHC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NUTRA PHARMA CORP reported a -49.01% year-over-year revenue growth, a Gross Profit Margin of 78.15% (TTM), a Debt-to-Equity ratio of -1.03x, a Price-to-Sales (P/S) ratio of 10.03x (TTM), a Price-to-Book (P/B) ratio of -0.08x (TTM), at a market cap of $1.61M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -49.01%
- Gross Profit Margin TTM
- 78.15%
- Debt To Equity
- -1.03x
- P/S TTM
- 10.03x
- P/B TTM
- -0.08x
- Market Cap
- $1.61M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NUTRA PHARMA CORP in?
NUTRA PHARMA CORP (NPHC) operates in the Medicinal Chemicals & Botanical Products industry.
What is NPHC's market cap?
NUTRA PHARMA CORP (NPHC) has a market capitalization of $1.61M as of 2026-06-30.
What exchange does NPHC trade on?
NUTRA PHARMA CORP (NPHC) trades on the OTC.
Where is NUTRA PHARMA CORP incorporated?
NUTRA PHARMA CORP is incorporated in CA.